Robert Crane - Feb 8, 2022 Form 3 Insider Report for Axcella Health Inc. (AXLA)

Role
Chief Financial Officer
Signature
/s/ Paul Fehlner, Attorney-in-Fact
Stock symbol
AXLA
Transactions as of
Feb 8, 2022
Transactions value $
$0
Form type
3
Date filed
2/28/2022, 03:25 PM
Next filing
Mar 18, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AXLA Stock Option (Right to Buy) Feb 8, 2022 Common Stock 200K $1.63 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying this option shall vest and become exercisable on February 8, 2023, with the remainder vesting in twelve equal quarterly installments thereafter, subject to subject to Reporting Person's continued service on each such vesting date

Remarks:

Exhibit 24 - Power of Attorney